Spectrum of Eosinophilic End-Organ Manifestations

Immunology and Allergy Clinics of North America

Volumn 35, Issue 3, 2015, Pages 403-411

  Akuthota, Praveen ^a   Weller, Peter F ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Churg Strauss syndrome; Eosinophilic esophagitis; Eosinophilic granulomatous vasculitis; Eosinophils immunology; Eosinophils pathology; Humans; Hypereosinophilic syndrome; Pulmonary eosinophilia

Indexed keywords

CARDIOVASCULAR SYSTEM; EOSINOPHILIA; GASTROINTESTINAL DISEASE; GASTROINTESTINAL TRACT; HEART DISEASE; HUMAN; INTEGUMENTARY SYSTEM; KIDNEY DISEASE; LOWER RESPIRATORY TRACT; LUNG DISEASE; NERVOUS SYSTEM; NEUROLOGIC DISEASE; ORGAN INJURY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SKIN DISEASE; UPPER RESPIRATORY TRACT; URINARY TRACT; CARDIAC MUSCLE; EOSINOPHIL; FIBROSIS; IMMUNOLOGY; LUNG; PATHOLOGY; THROMBOSIS;

EOSINOPHILIA; EOSINOPHILS; FIBROSIS; GASTROINTESTINAL TRACT; HUMANS; LUNG; MYOCARDIUM; THROMBOSIS;

EID: 84937729824     PISSN: 08898561     EISSN: 15578607     Source Type: Journal    
DOI: 10.1016/j.iac.2015.04.002     Document Type: Review

References (68)

1. Akuthota P., Wang H.B., Spencer L.A., et al. Immunoregulatory roles of eosinophils: a new look at a familiar cell. Clin Exp Allergy 2008, 38(8):1254-1263.
2. Shamri R., Xenakis J.J., Spencer L.A. Eosinophils in innate immunity: an evolving story. Cell Tissue Res 2011, 343(1):57-83.
3. Akuthota P., Weller P.F. Eosinophilic pneumonias. Clin Microbiol Rev 2012, 25(4):649-660.
4. DeBrosse C.W., Rothenberg M.E. Allergy and eosinophil-associated gastrointestinal disorders (EGID). Curr Opin Immunol 2008, 20(6):703-708.
5. Ogbogu P.U., Bochner B.S., Butterfield J.H., et al. Hypereosinophilic syndrome: a multicenter, retrospective analysis of clinical characteristics and response to therapy. J Allergy Clin Immunol 2009, 124(6):1319-1325.e3.
6. Vaglio A., Buzio C., Zwerina J. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): state of the art. Allergy 2013, 68(3):261-273.
7. Akuthota P., Weller P.F. Eosinophils and disease pathogenesis. Semin Hematol 2012, 49(2):113-119.
8. Carrington C.B., Addington W.W., Goff A.M., et al. Chronic eosinophilic pneumonia. N Engl J Med 1969, 280(15):787-798.
9. Tazelaar H.D., Linz L.J., Colby T.V., et al. Acute eosinophilic pneumonia: histopathologic findings in nine patients. Am J Respir Crit Care Med 1997, 155(1):296-302.
10. Noguchi H., Kephart G.M., Colby T.V., et al. Tissue eosinophilia and eosinophil degranulation in syndromes associated with fibrosis. Am J Pathol 1992, 140(2):521-528.
11. Gomes I., Mathur S.K., Espenshade B.M., et al. Eosinophil-fibroblast interactions induce fibroblast IL-6 secretion and extracellular matrix gene expression: implications in fibrogenesis. J Allergy Clin Immunol 2005, 116(4):796-804.
12. Levi-Schaffer F., Garbuzenko E., Rubin A., et al. Human eosinophils regulate human lung- and skin-derived fibroblast properties in vitro: a role for transforming growth factor beta (TGF-beta). Proc Natl Acad Sci U S A 1999, 96(17):9660-9665.
13. Shock A., Rabe K.F., Dent G., et al. Eosinophils adhere to and stimulate replication of lung fibroblasts 'in vitro'. Clin Exp Immunol 1991, 86(1):185-190.
14. Wong D.T., Elovic A., Matossian K., et al. Eosinophils from patients with blood eosinophilia express transforming growth factor beta 1. Blood 1991, 78(10):2702-2707.
15. Pincus S.H., Ramesh K.S., Wyler D.J. Eosinophils stimulate fibroblast DNA synthesis. Blood 1987, 70(2):572-574.
16. Zagai U., Lundahl J., Klominek J., et al. Eosinophil cationic protein stimulates migration of human lung fibroblasts in vitro. Scand J Immunol 2009, 69(4):381-386.
17. Zagai U., Dadfar E., Lundahl J., et al. Eosinophil cationic protein stimulates TGF-beta1 release by human lung fibroblasts in vitro. Inflammation 2007, 30(5):153-160.
18. Aceves S.S., Ackerman S.J. Relationships between eosinophilic inflammation, tissue remodeling, and fibrosis in eosinophilic esophagitis. Immunol Allergy Clin North Am 2009, 29(1):197-211. xiii-xiv.
19. Aceves S.S., Broide D.H. Airway fibrosis and angiogenesis due to eosinophil trafficking in chronic asthma. Curr Mol Med 2008, 8(5):350-358.
20. Ogbogu P.U., Rosing D.R., Horne M.K. Cardiovascular manifestations of hypereosinophilic syndromes. Immunol Allergy Clin North Am 2007, 27(3):457-475.
21. Akuthota P., Xenakis J.J., Weller P.F. Eosinophils: offenders or general bystanders in allergic airway disease and pulmonary immunity?. J Innate Immun 2011, 3(2):113-119.
22. Kita H. Eosinophils: multifaceted biological properties and roles in health and disease. Immunol Rev 2011, 242(1):161-177.
23. Warringa R.A., Schweizer R.C., Maikoe T., et al. Modulation of eosinophil chemotaxis by interleukin-5. Am J Respir Cell Mol Biol 1992, 7(6):631-636.
24. Yamaguchi Y., Hayashi Y., Sugama Y., et al. Highly purified murine interleukin 5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. IL-5 as an eosinophil chemotactic factor. J Exp Med 1988, 167(5):1737-1742.
25. Fajt M.L., Wenzel S.E. Asthma phenotypes and the use of biologic medications in asthma and allergic disease: The next steps toward personalized care. J Allergy Clin Immunol 2015, 135(2):299-310.
26. Simon D., Wardlaw A., Rothenberg M.E. Organ-specific eosinophilic disorders of the skin, lung, and gastrointestinal tract. J Allergy Clin Immunol 2010, 126(1):3-13.
27. Rohrbach M.S., Wheatley C.L., Slifman N.R., et al. Activation of platelets by eosinophil granule proteins. J Exp Med 1990, 172(4):1271-1274.
28. Slungaard A., Vercellotti G.M., Tran T., et al. Eosinophil cationic granule proteins impair thrombomodulin function. A potential mechanism for thromboembolism in hypereosinophilic heart disease. J Clin Invest 1993, 91(4):1721-1730.
29. Liapis H., Ho A.K., Brown D., et al. Thrombotic microangiopathy associated with the hypereosinophilic syndrome. Kidney Int 2005, 67(5):1806-1811.
30. Davis B.P., Rothenberg M.E. Eosinophils and gastrointestinal disease. Eosinophils in health and disease 2013, 484-493. Elsevier/Academic Press, London; Waltham (MA). 1st edition. J. Lee, H.F. Rosenberg (Eds.).
31. Rothenberg M.E., Mishra A., Collins M.H., et al. Pathogenesis and clinical features of eosinophilic esophagitis. J Allergy Clin Immunol 2001, 108(6):891-894.
32. Orenstein S.R., Shalaby T.M., Di Lorenzo C., et al. The spectrum of pediatric eosinophilic esophagitis beyond infancy: a clinical series of 30 children. Am J Gastroenterol 2000, 95(6):1422-1430.
33. Croese J., Fairley S.K., Masson J.W., et al. Clinical and endoscopic features of eosinophilic esophagitis in adults. Gastrointest Endosc 2003, 58(4):516-522.
34. Husain Z., Reddy B.Y., Schwartz R.A. DRESS syndrome: part I. Clinical perspectives. J Am Acad Dermatol 2013, 68(5):693.e1-693.e14.
35. Bjornsson E., Olsson R. Outcome and prognostic markers in severe drug-induced liver disease. Hepatology 2005, 42(2):481-489.
36. Abraham S.C., Leach S., Yeo C.J., et al. Eosinophilic pancreatitis and increased eosinophils in the pancreas. Am J Surg Pathol 2003, 27(3):334-342.
37. Janz D.R., O'Neal H.R., Ely E.W. Acute eosinophilic pneumonia: a case report and review of the literature. Crit Care Med 2009, 37(4):1470-1474.
38. Jederlinic P.J., Sicilian L., Gaensler E.A. Chronic eosinophilic pneumonia. A report of 19 cases and a review of the literature. Medicine (Baltimore) 1988, 67(3):154-162.
39. Kalomenidis I., Light R.W. Eosinophilic pleural effusions. Curr Opin Pulm Med 2003, 9(4):254-260.
40. Schleimer R.P., Kato A., Kern R. Eosinophils and chronic rhinosinusitis. Eosinophils in health and disease 2013, 508-519. Elsevier/Academic Press, London; Waltham (MA). 1st edition. J. Lee, H.F. Rosenberg (Eds.).
41. Van Zele T., Claeys S., Gevaert P., et al. Differentiation of chronic sinus diseases by measurement of inflammatory mediators. Allergy 2006, 61(11):1280-1289.
42. Neumann T., Manger B., Schmid M., et al. Cardiac involvement in Churg-Strauss syndrome: impact of endomyocarditis. Medicine (Baltimore) 2009, 88(4):236-243.
43. Dennert R.M., van Paassen P., Schalla S., et al. Cardiac involvement in Churg-Strauss syndrome. Arthritis Rheum 2010, 62(2):627-634.
44. Weller P.F., Bubley G.J. The idiopathic hypereosinophilic syndrome. Blood 1994, 83(10):2759-2779.
45. Tai P.C., Ackerman S.J., Spry C.J., et al. Deposits of eosinophil granule proteins in cardiac tissues of patients with eosinophilic endomyocardial disease. Lancet 1987, 1(8534):643-647.
46. Zientek D.M., King D.L., Dewan S.J., et al. Hypereosinophilic syndrome with rapid progression of cardiac involvement and early echocardiographic abnormalities. Am Heart J 1995, 130(6):1295-1298.
47. Shah R., Ananthasubramaniam K. Evaluation of cardiac involvement in hypereosinophilic syndrome: complementary roles of transthoracic, transesophageal, and contrast echocardiography. Echocardiography 2006, 23(8):689-691.
48. Syed I.S., Martinez M.W., Feng D.L., et al. Cardiac magnetic resonance imaging of eosinophilic endomyocardial disease. Int J Cardiol 2008, 126(3):e50-e52.
49. Plastiras S.C., Economopoulos N., Kelekis N.L., et al. Magnetic resonance imaging of the heart in a patient with hypereosinophilic syndrome. Am J Med 2006, 119(2):130-132.
50. Parrillo J.E., Borer J.S., Henry W.L., et al. The cardiovascular manifestations of the hypereosinophilic syndrome. Prospective study of 26 patients, with review of the literature. Am J Med 1979, 67(4):572-582.
51. Pitini V., Arrigo C., Azzarello D., et al. Serum concentration of cardiac Troponin T in patients with hypereosinophilic syndrome treated with imatinib is predictive of adverse outcomes. Blood 2003, 102(9):3456-3457. [author reply: 3457].
52. Sheikh J., Weller P.F. Clinical overview of hypereosinophilic syndromes. Immunol Allergy Clin North Am 2007, 27(3):333-355.
53. Masi A.T., Hunder G.G., Lie J.T., et al. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 1990, 33(8):1094-1100.
54. Comarmond C., Pagnoux C., Khellaf M., et al. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): clinical characteristics and long-term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort. Arthritis Rheum 2013, 65(1):270-281.
55. Moore P.M., Harley J.B., Fauci A.S. Neurologic dysfunction in the idiopathic hypereosinophilic syndrome. Ann Intern Med 1985, 102(1):109-114.
56. Simon D., Simon H.U. Eosinophils and skin diseases. Eosinophils in health and disease 2013, 442-448. Elsevier/Academic Press, London; Waltham (MA). 1st edition. J. Lee, H.F. Rosenberg (Eds.).
57. Adame J., Cohen P.R. Eosinophilic panniculitis: diagnostic considerations and evaluation. J Am Acad Dermatol 1996, 34(2 Pt 1):229-234.
58. Caputo R., Marzano A.V., Vezzoli P., et al. Wells syndrome in adults and children: a report of 19 cases. Arch Dermatol 2006, 142(9):1157-1161.
59. Doyle J.A., Ginsburg W.W. Eosinophilic fasciitis. Med Clin North Am 1989, 73(5):1157-1166.
60. Leiferman K.M. Eosinophils in atopic dermatitis. J Allergy Clin Immunol 1994, 94(6 Pt 2):1310-1317.
61. Gleich G.J., Schroeter A.L., Marcoux J.P., et al. Episodic angioedema associated with eosinophilia. N Engl J Med 1984, 310(25):1621-1626.
62. Praga M., Gonzalez E. Acute interstitial nephritis. Kidney Int 2010, 77(11):956-961.
63. Maripuri S., Grande J.P., Osborn T.G., et al. Renal involvement in primary Sjögren's syndrome: a clinicopathologic study. Clin J Am Soc Nephrol 2009, 4(9):1423-1431.
64. Casella F.J., Allon M. The kidney in sarcoidosis. J Am Soc Nephrol 1993, 3(9):1555-1562.
65. Kilic S., Erguvan R., Ipek D., et al. Eosinophilic cystitis. A rare inflammatory pathology mimicking bladder neoplasms. Urol Int 2003, 71(3):285-289.
66. Liu S., Miller P.D., Holmes S.A., et al. Eosinophilic prostatitis and prostatic specific antigen. Br J Urol 1992, 69(1):61-63.
67. Chen K.R., Su W.P., Pittelkow M.R., et al. Eosinophilic vasculitis syndrome: recurrent cutaneous eosinophilic necrotizing vasculitis. Semin Dermatol 1995, 14(2):106-110.
68. Selva-O'Callaghan A., Trallero-Araguas E., Grau J.M. Eosinophilic myositis: an updated review. Autoimmun Rev 2014, 13(4-5):375-378.